Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients

Only about one third of non—small-cell lung cancer (NSCLC) patients respond to cisplatin-based chemotherapy. Cisplatin DNA adducts are commonly repaired through the nucleotide excision repair pathway. The study of rare inherited disorders such as xeroderma pigmentosum and Cockayne syndrome has discl...

Full description

Bibliographic Details

Published in:	Clinical lung cancer Vol. 4; no. 4; pp. 237 - 241
Main Authors:	Camps, Carlos, Sarries, Carmen, Roig, Bárbara, Javier Sánchez, José, Queralt, Cristina, Sancho, Eva, Martinez, Natividad, Tarón, Miguel, Rosell, Rafael
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01.01.2003
Subjects:	Chemotherapy resistance Cockayne syndrome DNA adducts DNA repair ERCC1 Transcription-coupled repair Xeroderma pigmentosum genes Cockayne syndrome Chemotherapy resistance ERCC1 DNA adducts DNA repair Transcription-coupled repair Xeroderma pigmentosum genes
ISSN:	1525-7304, 1938-0690
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!